Concepedia
Statistics
Publications
45
Citations
1.9K
H-Index
24
Active since
1982
Affiliations
Ramathibodi Hospital(Current)
Mahidol University
The Catholic University of Korea Seoul St. Mary's Hospital
Catholic University of Korea
Novartis (Switzerland)
Saengsuree Jootar is an author at Ramathibodi Hospital specializing in medicine, hematology, and chronic myeloid leukemia therapy.
Publications per year
1982–2020
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial
Hagop Kantarjian, Ricardo Pasqüini, Nelson Hamerschlak et al. · Blood · 2007 · 378 citations · Full text
Medicine, Hematology, Oncology +5
Dasatinib or high‐dose imatinib for chronic‐phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily
Hagop M. Kantarjian, Ricardo Pasqüini, Vincent Lévy et al. · Cancer · 2009 · 213 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +10
Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
Kearkiat Praditpornsilpa, Khajohn Tiranathanagul, Pawinee Kupatawintu et al. · Kidney International · 2011 · 107 citations · Full text
Life Sciences, Immunology, Pharmacology +5
Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Jae-Yong Kwak, Sung‐Hyun Kim, Suk Joong Oh et al. · Clinical Cancer Research · 2017 · 77 citations
Medicine, Pharmacology, Pharmacotherapy +11
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors
S.-H. Kim, Hari Menon, Saengsuree Jootar et al. · Haematologica · 2014 · 70 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 45